172 related articles for article (PubMed ID: 25413103)
1. Clinical and immunological significance of HLA-E in stem cell transplantation and cancer.
Wieten L; Mahaweni NM; Voorter CE; Bos GM; Tilanus MG
Tissue Antigens; 2014 Dec; 84(6):523-35. PubMed ID: 25413103
[TBL] [Abstract][Full Text] [Related]
2. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
Sullivan LC; Clements CS; Rossjohn J; Brooks AG
Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
[TBL] [Abstract][Full Text] [Related]
3. Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival.
Guberina H; Rebmann V; Wagner B; da Silva Nardi F; Dziallas P; Dolff S; Bienholz A; Wohlschlaeger J; Bankfalvi A; Heinemann FM; Witzke O; Zoet YM; Claas FH; Horn PA; Kribben A; Doxiadis II
Immunobiology; 2017 Mar; 222(3):536-543. PubMed ID: 27871782
[TBL] [Abstract][Full Text] [Related]
4. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the HLA-E and CD94/NKG2 interaction.
Iwaszko M; Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):353-67. PubMed ID: 21800130
[TBL] [Abstract][Full Text] [Related]
6. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
9. HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity.
Djaoud Z; Parham P
Annu Rev Biochem; 2020 Jun; 89():717-739. PubMed ID: 32569519
[TBL] [Abstract][Full Text] [Related]
10. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.
Pietra G; Romagnani C; Manzini C; Moretta L; Mingari MC
J Biomed Biotechnol; 2010; 2010():907092. PubMed ID: 20634877
[TBL] [Abstract][Full Text] [Related]
12. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
13. Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.
Sasaki T; Kanaseki T; Shionoya Y; Tokita S; Miyamoto S; Saka E; Kochin V; Takasawa A; Hirohashi Y; Tamura Y; Miyazaki A; Torigoe T; Hiratsuka H; Sato N
Eur J Immunol; 2016 Apr; 46(4):929-40. PubMed ID: 26711740
[TBL] [Abstract][Full Text] [Related]
14. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
15. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
[TBL] [Abstract][Full Text] [Related]
16. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
18. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
[TBL] [Abstract][Full Text] [Related]
19. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
20. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
